The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Europe CBD oil market is expected to exhibit a CAGR of 21.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Cannabidiol (CBD) refers to a non-psychoactive compound extracted from leaves, resin, and flowers of the marijuana or hemp (cannabis) plant. CBD oil is mainly produced by extracting CBD from the cannabis plant and further diluting it with a carrier oil, such as coconut or hemp seed oil. The oil is widely adopted for numerous medicinal purposes due to the absence of psychoactive effects, such as reducing depression, relieving pain, improving heart health, alleviating cancer-related symptoms, treating acne, etc.
The rising legalization of cannabidiol across several European countries is propelling the market for CBD oil. The growing prevalence of various neurological and psychiatric ailments is also driving the demand of CBD oil for treating insomnia, reducing anxiety, minimizing stress levels, improving seizures, etc. In line with this, CBD oil-infused supplements are also adopted in cancer treatment for relieving adverse health effects of chemotherapy, such as inflammation, nausea, insomnia, weight loss, etc. Moreover, significant growth in the pharmaceutical industry along with the increasing use of bioactive ingredients in drugs is further catalyzing the use of CBD oil based on its high content of iron, protein, fiber, zinc, etc. Additionally, the expanding utilization of CBD oil in the cosmetics and personal care sectors based on its antioxidation, anti-aging, and anti-inflammatory properties is also augmenting the market growth in the region. In the coming years, the rising investments by several private and government organizations in extensive R&D activities for cannabinoids will continue to drive the CBD oil market in Europe.
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe CBD oil market, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on source, product type, product category, application and distribution channel.
Breakup by Source:
Breakup by Product Type:
Breakup by Product Category:
Breakup by Application:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined with some of the key players being Aurora Cannabis, Diamond CBD Inc., ENDOCA, APHRIA Inc., ConnOils LLC, Elixinol Global Limited, Emblem CANNABIS, NuLeaf Naturals, LLC, CBD Ultra Limited and The Original Alternative Limited.
|Base Year of the Analysis||2021|
|Segment Coverage||Source, Product Type, Product Category, Application, Distribution Channel, Country|
|Countries Covered||Germany, Spain, Italy, France, United Kingdom, Russia, Rest of Europe|
|Companies Covered||Aurora Cannabis, Diamond CBD Inc., ENDOCA, APHRIA Inc., ConnOils LLC, Elixinol Global Limited, Emblem CANNABIS, NuLeaf Naturals, LLC, CBD Ultra Limited and The Original Alternative Limited|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
Home Healthcare Market by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at